Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Private hospital and phase I.

M Gallet1, P Nony

  • 1Unité de Pharmacologie Clinique, Hôpital Saint-Joseph, Lyon, France.

Fundamental & Clinical Pharmacology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug.

Medical & biological engineering & computing·2023
Same author

Determination of the optimal dose of ephedrine in the treatment of arterial hypotension due to general anesthesia in neonates and infants below 6 months old: the ephedrine study protocol for a randomized, open-label, controlled, dose escalation trial.

Trials·2021
Same author

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis.

Thrombosis research·2020
Same author

Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shock.

In silico biology·2020
Same author

Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients.

Mathematical medicine and biology : a journal of the IMA·2017
Same author

Conditions of microvessel occlusion for blood coagulation in flow.

International journal for numerical methods in biomedical engineering·2016
Same journal

The Challenges of Scientific Publishing: An Editor-In-Chief's Perspective.

Fundamental & clinical pharmacology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms.

Fundamental & clinical pharmacology·2026
Same journal

TAAR1-Associated Trace Amines for Cutaneous Nociceptive Blockade in Rats.

Fundamental & clinical pharmacology·2026
Same journal

Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia-Reperfusion Injury.

Fundamental & clinical pharmacology·2026
Same journal

Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis- and Angiogenesis-Related Proteins.

Fundamental & clinical pharmacology·2026
Same journal

Nebivolol Protects the Thoracic and Abdominal Aorta and Their Perivascular Adipose Tissue From the Differential Detrimental Effects of Obesity.

Fundamental & clinical pharmacology·2026
See all related articles

French law permits phase I clinical trials in both public and private hospitals. Private hospitals adhere to the same scientific standards and good clinical practices, raising the question of integrating clinical pharmacology research.

Area of Science:

  • Clinical Pharmacology
  • Medical Research Ethics

Background:

  • French legislation since December 1988 permits phase I studies.
  • Phase I units can be established in both public and private healthcare settings.

Purpose of the Study:

  • To evaluate the feasibility and appropriateness of integrating clinical pharmacology and healthy volunteer investigations into private hospital policies.
  • To assess the current regulatory and practical landscape for phase I studies in French private hospitals.

Main Methods:

  • Analysis of French legislation pertaining to clinical trials.
  • Review of scientific and ethical standards for phase I units.
  • Examination of the operational capabilities of private hospitals for conducting clinical research.

Main Results:

Related Experiment Videos

  • Private hospitals are subject to the same scientific standards as public hospitals for clinical trials.
  • Practitioners in private hospitals possess awareness of good clinical practices and methodological constraints.
  • Phase I units are structurally feasible in private hospital settings.

Conclusions:

  • Private hospitals meet the necessary standards to conduct phase I clinical trials.
  • The integration of clinical pharmacology research in private hospitals is a relevant policy consideration.